These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36700320)

  • 1. Efficacy and Safety of Escitalopram, Desvenlafaxine, and Vortioxetine in the Acute Treatment of Anxious Depression: A Randomized Rater-blinded 6-week Clinical Trial.
    Shin C; Jeon SW; Lee SH; Pae CU; Hong N; Lim HK; Patkar AA; Masand PS; An H; Han C
    Clin Psychopharmacol Neurosci; 2023 Feb; 21(1):135-146. PubMed ID: 36700320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study.
    Lee SH; Jeon SW; Shin C; Pae CU; Patkar AA; Masand PS; An H; Han C
    Psychiatry Investig; 2022 Apr; 19(4):268-280. PubMed ID: 35500900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
    Soares CN; Thase ME; Clayton A; Guico-Pabia CJ; Focht K; Jiang Q; Kornstein SG; Ninan PT; Kane CP
    CNS Drugs; 2011 Mar; 25(3):227-38. PubMed ID: 21323394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of escitalopram versus desvenlafaxine in the treatment of major depression: A preliminary 1-year prospective randomized open label comparative trial.
    Gupta BM; Zargar SH; Arora M; Tandon VR
    Perspect Clin Res; 2016; 7(1):45-50. PubMed ID: 26955576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical effectiveness and safety of escitalopram and desvenlafaxine in patients of depression with anxiety: a randomized, open-label controlled trial.
    Maity N; Ghosal MK; Gupta A; Sil A; Chakraborty S; Chatterjee S
    Indian J Pharmacol; 2014; 46(4):433-7. PubMed ID: 25097285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Efficacy and Safety of Escitalopram versus Desvenlafaxine in Postmenopausal Women with Depression and Anxiety: A Randomized, Open-Label, Comparative Trial.
    Mahajan SS; Tandon VR; Arora M; Mahajan A; Kotwal S
    J Midlife Health; 2019; 10(3):141-146. PubMed ID: 31579188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of desvenlafaxine 50 mg/day on a subpopulation of anxious/depressed patients: a pooled analysis of seven randomized, placebo-controlled studies.
    Kornstein SG; Guico-Pabia CJ; Fayyad RS
    Hum Psychopharmacol; 2014 Sep; 29(5):492-501. PubMed ID: 25196042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine.
    Sun Y; Drevets W; Turecki G; Li QS
    Brain Behav Immun; 2020 Jul; 87():404-412. PubMed ID: 31978524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desvenlafaxine and escitalopram for the treatment of postmenopausal women with major depressive disorder.
    Soares CN; Thase ME; Clayton A; Guico-Pabia CJ; Focht K; Jiang Q; Kornstein SG; Ninan P; Kane CP; Cohen LS
    Menopause; 2010 Jul; 17(4):700-11. PubMed ID: 20539246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram.
    Jacobsen PL; Nomikos GG; Zhong W; Cutler AJ; Affinito J; Clayton A
    CNS Spectr; 2020 Feb; 25(1):50-63. PubMed ID: 31010445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming functional impairment in postpartum depressed or anxious women: a pilot trial of desvenlafaxine with flexible dosing.
    Misri S; Swift E; Abizadeh J; Shankar R
    Ther Adv Psychopharmacol; 2016 Aug; 6(4):269-76. PubMed ID: 27536346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in Quality of Life of Postmenopausal Women with Depression with commonly used Antidepressants (Escitalopram vs. Desvenlafaxine): A Randomized Controlled Trial in a Tertiary Care Teaching Hospital of North India.
    Mahajan SS; Arora M; Tandon VR; Mahajan A; Kotwal S
    J Midlife Health; 2022; 13(1):80-84. PubMed ID: 35707303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.
    Jacobsen PL; Mahableshwarkar AR; Chen Y; Chrones L; Clayton AH
    J Sex Med; 2015 Oct; 12(10):2036-48. PubMed ID: 26331383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled 6-wk trial of the efficacy and tolerability of 5 mg vortioxetine in adults with major depressive disorder.
    Jain R; Mahableshwarkar AR; Jacobsen PL; Chen Y; Thase ME
    Int J Neuropsychopharmacol; 2013 Mar; 16(2):313-21. PubMed ID: 22963932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A controlled study of the efficacy and safety of tandospirone citrate combined with escitalopram in the treatment of vascular depression: A pilot randomized controlled trial at a single-center in China.
    Chen H; Lin Q; Lin T; Lin Y; Lin X; Chen R; Luo L; Lin F; Xiao Y
    J Psychiatr Res; 2019 Jul; 114():133-140. PubMed ID: 31075722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Potential of Vortioxetine for Anxious Depression: A Post Hoc Analysis of Data from a Clinical Trial Conducted in Japan.
    Inoue T; Fujimoto S; Marumoto T; Kitagawa T; Ishida K; Nakajima T; Moriguchi Y; Fujikawa K; Watanabe K
    Neuropsychiatr Dis Treat; 2021; 17():3781-3790. PubMed ID: 34992372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms of anxiety in depression: assessment of item performance of the Hamilton Anxiety Rating Scale in patients with depression.
    Vaccarino AL; Evans KR; Sills TL; Kalali AH
    Depress Anxiety; 2008; 25(12):1006-13. PubMed ID: 18800370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative efficacy and tolerability of vortioxetine versus selected antidepressants by indirect comparisons of similar clinical studies.
    Llorca PM; Lançon C; Brignone M; Rive B; Salah S; Ereshefsky L; Francois C
    Curr Med Res Opin; 2014 Dec; 30(12):2589-606. PubMed ID: 25249164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.